PubRank

W Kern

Author PubWeight™ 140.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 2006 2.28
2 Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007 1.97
3 The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991 1.81
4 Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004 1.77
5 The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype. Leukemia 2008 1.76
6 Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype. Leukemia 2008 1.70
7 Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML. Leukemia 2010 1.65
8 SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013 1.57
9 Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia 2012 1.57
10 Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991 1.53
11 Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991 1.51
12 Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia 2011 1.45
13 ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia 2012 1.42
14 Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity. Leukemia 2009 1.40
15 Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E. Leukemia 2006 1.40
16 Landscape of TET2 mutations in acute myeloid leukemia. Leukemia 2011 1.35
17 New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes. Leukemia 2005 1.32
18 A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases. Leukemia 2011 1.31
19 AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 2009 1.27
20 The selfish brain: competition for energy resources. Prog Brain Res 2006 1.26
21 Management of acute myeloid leukemia in elderly patients. J Clin Oncol 1999 1.25
22 Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis. Leukemia 2007 1.22
23 Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia. Leukemia 2011 1.18
24 Dependence of age-specific incidence of acute myeloid leukemia on karyotype. Blood 2001 1.17
25 [Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany]. Pneumologie 2009 1.15
26 Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci 2010 1.13
27 Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia. Leukemia 2005 1.12
28 Obese men respond to cognitive but not to catabolic brain insulin signaling. Int J Obes (Lond) 2007 1.11
29 Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 2005 1.09
30 Low cerebrospinal fluid insulin levels in obese humans. Diabetologia 2006 1.08
31 High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia 2009 1.07
32 Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 1999 1.05
33 Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol 1997 1.03
34 Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 2000 1.03
35 Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients. Leukemia 2013 1.03
36 Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics. Leukemia 2013 1.03
37 Landmark analysis of DNMT3A mutations in hematological malignancies. Leukemia 2013 1.02
38 Cadmium and lead in the smoke of a filter cigarette. Sci Total Environ 1993 1.02
39 Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia 2011 1.01
40 Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol 1997 1.01
41 Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 2004 1.01
42 STAT3 mutations are highly specific for large granular lymphocytic leukemia. Leukemia 2012 1.00
43 AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions. Leukemia 2010 1.00
44 GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia 2012 1.00
45 Aldehydic lipid peroxidation products derived from linoleic acid. Biochim Biophys Acta 2001 0.98
46 [S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie 2005 0.97
47 JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML. Leukemia 2006 0.97
48 Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure. Leukemia 2011 0.96
49 Nocturnal adrenocorticotropin and cortisol secretion depends on sleep duration and decreases in association with spontaneous awakening in the morning. J Clin Endocrinol Metab 1992 0.96
50 [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)]. Anaesthesist 2010 0.96
51 Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms. Leukemia 2011 0.95
52 Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial. J Med Genet 2008 0.94
53 Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 2006 0.93
54 Night-time plasma cortisol secretion is associated with specific sleep stages. Biol Psychiatry 1986 0.93
55 An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling. Leukemia 2011 0.93
56 High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia. Leukemia 2013 0.93
57 Adaptation of cognitive function to hypoglycemia in healthy men. Diabetes Care 2000 0.93
58 Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol 2007 0.93
59 Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients. Eur J Clin Pharmacol 2001 0.92
60 The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML. Leukemia 2011 0.92
61 Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans. Int J Obes (Lond) 2005 0.91
62 Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia. Br J Haematol 2001 0.91
63 A comparative study of polymerization lamps to determine the degree of cure of composites using infrared spectroscopy. Eur J Orthod 2004 0.91
64 Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients. Leukemia 2007 0.89
65 Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab 1999 0.89
66 The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. J Clin Endocrinol Metab 2001 0.89
67 A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene. Leukemia 2012 0.88
68 Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature. Infection 1992 0.88
69 Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans. Clin Pharmacol Ther 2001 0.87
70 [How many nosocomial infections are avoidable?]. Dtsch Med Wochenschr 2010 0.87
71 Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials. Cancer 2000 0.86
72 Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection 1988 0.86
73 Gain of an isochromosome 5p: a new recurrent chromosome abnormality in acute monoblastic leukemia. Cancer Genet Cytogenet 2001 0.85
74 Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria. Metabolism 1999 0.85
75 Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment. Leukemia 2009 0.85
76 Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia 2003 0.85
77 Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype. Leukemia 2012 0.85
78 Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 1991 0.85
79 Hypoglycemia, but not insulin, acutely decreases LH and T secretion in men. J Clin Endocrinol Metab 2001 0.84
80 Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the cases. Leukemia 2011 0.84
81 Corticotropin-releasing hormone-induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness. J Clin Endocrinol Metab 1993 0.84
82 [Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies]. Klin Padiatr 2012 0.84
83 Comparative bond strength of new and reconditioned brackets and assessment of residual adhesive by light and electron microscopy. Eur J Orthod 2010 0.83
84 Interactive diagnostics in the indication to allogeneic SCT in AML. Bone Marrow Transplant 2009 0.83
85 Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient. Transpl Infect Dis 2010 0.83
86 Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 1989 0.83
87 Influences of corticosteroids, dexamethasone and hydrocortisone on sleep in humans. Neuropsychobiology 1986 0.83
88 Hyperinsulinemia causes activation of the hypothalamus-pituitary-adrenal axis in humans. Int J Obes Relat Metab Disord 2001 0.83
89 Orbito-sphenoidal Aspergillus infection mimicking cluster headache: a case report. Cephalalgia 1997 0.83
90 The effect of experimentally induced insulin resistance on the leptin response to hyperinsulinaemia. Int J Obes Relat Metab Disord 2002 0.83
91 Towards a pathogenesis-oriented therapy of acute myeloid leukemia. Crit Rev Oncol Hematol 2005 0.83
92 JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases. Leukemia 2007 0.82
93 Leukaemic blasts differ from normal bone marrow mononuclear cells and CD34+ haemopoietic stem cells in their metabolism of cytosine arabinoside. Br J Haematol 1999 0.82
94 A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment. Leukemia 2007 0.82
95 SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis. Leukemia 2013 0.82
96 Differential adaptation of neurocognitive brain functions to recurrent hypoglycemia in healthy men. Psychoneuroendocrinology 2005 0.81
97 Auditory reflex thresholds elevated by stress-induced cortisol secretion. Psychoneuroendocrinology 1993 0.80
98 Corynebacterium jeikeium bacteremia at a tertiary care center. Infection 1991 0.80
99 Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia. Pneumologie 2010 0.80
100 Observation of exotic meson production in the reaction pi- p --> eta'pi- p at 18 GeV/c. Phys Rev Lett 2001 0.80
101 Gene expression profiling for the diagnosis of acute leukaemia. Br J Cancer 2006 0.80
102 [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults]. Dtsch Med Wochenschr 2010 0.79
103 New insights into the biology of acute myeloid leukemia and their impact on treatment. Verh Dtsch Ges Pathol 2003 0.79
104 Vasopressin regulates human sleep by reducing rapid-eye-movement sleep. Am J Physiol 1992 0.79
105 The clinical course and treatment results of patients with postresection locally recurrent lung cancer. Cancer 1978 0.79
106 A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol Psychiatry 1997 0.79
107 Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. Leukemia 2011 0.79
108 Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology? Eur J Pharmacol 2000 0.79
109 The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity. Br J Haematol 2000 0.79
110 Effects of diurnal sleep on secretion of cortisol, luteinizing hormone, and growth hormone in man. J Clin Endocrinol Metab 1994 0.78
111 Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine. Br J Haematol 2000 0.78
112 Fetal pericardial effusion. Am J Obstet Gynecol 1989 0.78
113 Preserved hypothermic response to hypoglycemia after antecedent hypoglycemia. Metabolism 2000 0.78
114 Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells. Ann Hematol 1999 0.78
115 Selective decontamination in neutropenic patients. Epidemiol Infect 1992 0.78
116 Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics. Leukemia 1998 0.78
117 Use of five-color staining improves the sensitivity of multiparameter flow cytomeric assessment of minimal residual disease in patients with acute myeloid leukemia. Leuk Lymphoma 2007 0.78
118 Antecedent hypoglycaemia attenuates vascular endothelial growth factor response to subsequent hypoglycaemia in healthy men. Diabet Med 2005 0.78
119 Fatigue and hyponatremia in a 75-year-old woman: unusual presentation of hypophysitis. Exp Clin Endocrinol Diabetes 2001 0.78
120 Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature. Leuk Lymphoma 2004 0.78
121 Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation. Scand J Infect Dis 1988 0.78
122 Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH). Ann Hematol 2004 0.78
123 Association of antidiabetic therapies to glycemic control and to body weight in type 2 diabetes: a German multicenter analysis on 9294 patients. Exp Clin Endocrinol Diabetes 2010 0.78
124 Classically conditioned changes of blood glucose level in humans. Physiol Behav 1993 0.78
125 A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 1996 0.77
126 Sleep-associated augmentation and synchronization of luteinizing hormone pulses in adult men. Neuroendocrinology 1991 0.77
127 Nocturnal wakefulness inhibits growth hormone (GH)-releasing hormone-induced GH secretion. J Clin Endocrinol Metab 1995 0.77
128 Gas chromatographic-electron impact mass spectrometric screening procedure for unknown hydroxyaldehydic lipid peroxidation products after pentafluorobenzyloxime derivatization. J Chromatogr B Biomed Appl 1995 0.77
129 Metformin does not adversely affect hormonal and symptomatic responses to recurrent hypoglycemia. J Clin Endocrinol Metab 2001 0.77
130 Comparison of the inhibitory effect of insulin and hypoglycemia on insulin secretion in humans. Metabolism 2000 0.77
131 Entrainment of nocturnal pituitary-adrenocortical activity to sleep processes in man--a hypothesis. Exp Clin Endocrinol 1993 0.77
132 Prevention of infection in acute leukemia. Haematol Blood Transfus 1990 0.77
133 Cortisol effects on attentional processes in man as indicated by event-related potentials. Psychophysiology 1987 0.76
134 Rhythms of pituitary-adrenal activity during sleep in patients with Cushing's disease. Exp Clin Endocrinol Diabetes 2000 0.76
135 Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells. Ther Drug Monit 1996 0.76
136 Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 1993 0.76
137 [Diagnostics of acute leukemias: interaction of phenotypic and genetic methods]. Pathologe 2012 0.76
138 Subgroup specific therapy effects in AML: AMLCG data. Ann Hematol 2004 0.76
139 Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve. Leukemia 1997 0.76
140 Genetic classification of acute myeloid leukemia (AML). Ann Hematol 2004 0.75
141 Exotic meson decay to omegapi0pi-. Phys Rev Lett 2005 0.75
142 [Diagnosis of leukemia using microarray technology]. Dtsch Med Wochenschr 2002 0.75
143 Prognostic significance of cytogenetics in relapsed acute myeloid leukaemia. Br J Haematol 2000 0.75
144 [Abortion following ultra-short-wave hyperthermia. Animal experiment studies]. Arch Gynakol 1970 0.75
145 Counter-regulatory hormone responses to human and porcine insulin induced hypoglycaemia. Lancet 1990 0.75
146 Influence of sex differences in subcutaneous fat mass on serum leptin concentrations. Diabetes Care 1998 0.75
147 Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma. Blood Cancer J 2012 0.75
148 Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia. Blood Cancer J 2012 0.75
149 [Coagulation, microcirculation and acute radiation reactions of the skin. Comparative study of skin reaction using conventional radiotherapy of breast carcinoma in combination with preventive marcumar-induced coagulation inhibition]. Fortschr Geb Rontgenstr Nuklearmed 1972 0.75
150 Experimental carotenoid retinopathy. II. Functional and morphological alterations of the rabbit retina after acute canthaxanthin application with small unilamellar phospholipid liposomes. Graefes Arch Clin Exp Ophthalmol 1987 0.75
151 [Malaria tropica]. Dtsch Med Wochenschr 1992 0.75
152 Experimental carotenoid retinopathy. I. Functional and morphological alterations of the rabbit retina after 11 months dietary carotenoid application. Graefes Arch Clin Exp Ophthalmol 1987 0.75
153 [Abnormalities and intra-uterine death following microwave therapy in early pregnancy. Animal experiments]. Munch Med Wochenschr 1972 0.75
154 [Haemophilus endocarditis]. Med Klin (Munich) 1992 0.75
155 2-Mercapto-1-methyl-5-methylmercapto-imidazole: a new metabolite of thiamazole. Xenobiotica 1983 0.75
156 Radiotherapy for suspected lung cancer not proved by tissue diagnosis. Chest 1973 0.75
157 [Standardization of radiotherapy of neoplasms located near to the base of the skull]. Fortschr Geb Rontgenstr Nuklearmed 1972 0.75
158 Priming with G-CSF in acute myeloid leukemia: preliminary data of the AMLCG. Ann Hematol 2004 0.75
159 Fragments of ACTH affect electrophysiological signs of controlled stimulus processing in humans. Psychopharmacology (Berl) 1989 0.75
160 Lymphangitic carcinomatosis: lung scan abnormalities. J Nucl Med 1976 0.75
161 [Prevention and follow-up care of sepsis. 1st revision of S2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V., DSG) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin, DIVI)]. Internist (Berl) 2010 0.75
162 [Fish breeder granuloma: infection caused by Mycobacterium marinum and other atypical mycobacteria in the human. Analysis of 8 cases and review of the literature]. Med Klin (Munich) 1989 0.75
163 [Isolated cerebral mucormycosis in leukemia]. Mykosen 1986 0.75
164 Chronic systemic aspergillosis. Mycoses 1997 0.75
165 Lymphangitic carcinomatosis of the lung: pathologic, diagnostic and therapeutic considerations. Int J Radiat Oncol Biol Phys 1977 0.75
166 [Nd:YAG laser effects on the anterior capsule of rabbit lenses]. Fortschr Ophthalmol 1988 0.75
167 [Functional treatment of vertebral fractures at the transition point between the thoracic and lumbar regions by means of the 3-point corset]. Hefte Unfallheilkd 1980 0.75
168 Lesion and regeneration of the anterior and posterior lens capsule and cortex in rabbits Nd:YAG laser. Graefes Arch Clin Exp Ophthalmol 1989 0.75
169 [Liposomes--drug carriers for retinally active drugs?]. Fortschr Ophthalmol 1989 0.75
170 Impact of the simultaneous administration of the (+)- and (-)-forms of formyl-tetrahydrofolic acid on plasma and intracellular pharmacokinetics of (-)-tetrahydrofolic acid. Cancer Chemother Pharmacol 2000 0.75
171 The lenticular capsule and cellular migration in anterior capsular cataract. Graefes Arch Clin Exp Ophthalmol 1986 0.75
172 [On the treatment of lethal radiation damage with vasodilators]. Strahlentherapie Sonderb 1965 0.75
173 [Tumor therapy with high frequency hyperthermia (decimeter-waves). Animal experiments]. Biomed Tech (Berl) 1971 0.75
174 Spectral encoding of the polarization state of light in multiplexed polarization-sensitive lasing structures. Opt Lett 2004 0.75
175 Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve. Leukemia 1996 0.75
176 Response to cytarabine ocfosfate (YNK01) in a patient with chronic lymphocytic leukemia refractory to treatment with chlorambucil/prednisone, fludarabine, and prednimustine/mitoxantrone. Ann Hematol 1996 0.75
177 Cisplatin nephrotoxicity in children after continuous 72-h and 3x1-h infusions. Pediatr Nephrol 2001 0.75
178 [Treatment with oral antibiotics of febrile neutropenia in onco-haematology. The experience of the EORTC antimicrobial group]. Presse Med 2004 0.75
179 All-optical tunability of holographically multiplexed organic distributed feedback lasers. Opt Express 2004 0.75
180 [Diphenylhydantoin in AIDS]. Dtsch Med Wochenschr 1986 0.75
181 Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet's disease. Scand J Rheumatol 1999 0.75
182 Removal of the antibacterial activity of trimethoprim-sulfamethoxazole, ofloxacin and zidovudine by BACTEC resin-containing blood culture medium. Zentralbl Bakteriol 1991 0.75
183 [Fever as a cause of abortion]. Med Klin 1972 0.75
184 [Can high maternal fever cause abnormalities in the child?]. Geburtshilfe Frauenheilkd 1971 0.75
185 [Accidents in childhood]. Osterr Hebammenztg 1967 0.75
186 Impact of sleep on the circadian excursions in the pituitary gonadotropin responsiveness of early follicular phase women. J Clin Endocrinol Metab 1993 0.75
187 [Hyperthermia treatment of malignant neoplasms]. Med Klin 1973 0.75
188 ICSH: on board for new projects. Int J Lab Hematol 2014 0.75
189 Use of leisure time activities for work adjustment training. Ment Retard 1979 0.75
190 Modern diagnostics in chronic myeloproliferative diseases (CMPDs). Ann Hematol 2004 0.75
191 Protective effect of insulin against hypoglycemia-associated counterregulatory failure. J Clin Endocrinol Metab 1999 0.75